Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial

Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Minor visual and layout adjustments on the Study Details page; core study content, including eligibility criteria, primary outcomes, locations, and enrollment, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:01:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Overall, the page updates its operating status notice and increases the version to v3.2.0, while removing the Huntington disease resource reference and the older v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-06T05:28:57.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Minor update: version bumped from v3.0.1 to v3.0.2 and the 'Back to Top' link removed; core content and time-sensitive data remain unchanged.
    Difference
    0.2%
    Check dated 2025-09-14T19:05:11.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T15:06:31.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically clarifying the location as Washington D.C., District of Columbia, United States, 20007, and has added information regarding Huntington's disease and congenital diseases.
    Difference
    1%
    Check dated 2025-08-31T11:45:56.000Z thumbnail image

Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.